婦人科癌治療薬の世界市場レポート 2023年以下を含む1) タイプ別アルキル化剤;植物アルカロイド;アントラサイクリン;抗腫瘍抗生物質2) 治療様式別:化学療法;標的療法;ホルモン療法3) 適応症別子宮頸癌、子宮体癌、卵巣・卵管癌、外陰癌、膣癌4) エンドユーザー別病院; クリニック; 癌専門治療センターrsCovering:ファイザー;ジョンソン・エンド・ジョンソン;エフ・ホフマン・ラ・ロシュ;アッヴィ;バイエルGynecological Cancer Drugs Global Market Report 2023Including: 1) By Type: Alkylating Agent; Plant Alkaloid; Anthracyclines; Antitumor Antibiotic2) By Therapeutic Modality: Chemotherapy; Targeted Therapy; Hormonal Therapy3) By Indication: Cervical Cancer; Uterine Cancer; Ovarian and Fallopian Tube Cancer; Vulvar Cancer; Vaginal Cancer4) By End Users: Hospitals; Clinics; Specialized Cancer Treatment CentersrsCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG The Business Research Companyの婦人科癌治療薬の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは、力強い成長を遂... もっと見る
サマリーThe Business Research Companyの婦人科癌治療薬の世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは、力強い成長を遂げている婦人科癌治療薬市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 婦人科がん治療薬の最大かつ最速の成長市場はどこか?同市場は経済全体、人口動態、他の類似市場とどのように関連しているのか?今後どのような力が市場を形成していくのか?ビジネスリサーチ社の婦人科癌治療薬世界市場レポートでは、このような疑問やその他多くの疑問にお答えします。 市場の特徴、規模と成長、セグメンテーション、地域別および国別内訳、競合環境、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場:1) タイプ別アルキル化剤;植物アルカロイド;アントラサイクリン;抗腫瘍抗生物質;その他のタイプ 2) 治療様式別化学療法;標的療法;ホルモン療法 3) 適応症別子宮頸癌、子宮体癌、卵巣・卵管癌、外陰癌、膣癌 4) エンドユーザー別病院、クリニック、がん治療専門医療機関、その他エンドユーザー 言及された企業ファイザー;ジョンソン・エンド・ジョンソン;エフ・ホフマン・ラ・ロシュ;アッヴィ;バイエル 国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Gynecological Cancer Drugs Market Characteristics 3. Gynecological Cancer Drugs Market Trends And Strategies 4. Gynecological Cancer Drugs Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Gynecological Cancer Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Gynecological Cancer Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Gynecological Cancer Drugs Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Gynecological Cancer Drugs Market Segmentation 6.1. Global Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Alkylating Agent Plant Alkaloid Anthracyclines Antitumor Antibiotic Other Types 6.2. Global Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Chemotherapy Targeted Therapy Hormonal Therapy 6.3. Global Gynecological Cancer Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Cervical Cancer Uterine Cancer Ovarian and Fallopian Tube Cancer Vulvar Cancer Vaginal Cancer 6.4. Global Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospitals Clinics Specialized Cancer Treatment Centers Other End Users 7. Gynecological Cancer Drugs Market Regional And Country Analysis 7.1. Global Gynecological Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Gynecological Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Gynecological Cancer Drugs Market 8.1. Asia-Pacific Gynecological Cancer Drugs Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Gynecological Cancer Drugs Market 9.1. China Gynecological Cancer Drugs Market Overview 9.2. China Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Gynecological Cancer Drugs Market 10.1. India Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Gynecological Cancer Drugs Market 11.1. Japan Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Gynecological Cancer Drugs Market 12.1. Australia Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Gynecological Cancer Drugs Market 13.1. Indonesia Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Gynecological Cancer Drugs Market 14.1. South Korea Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Gynecological Cancer Drugs Market 15.1. Western Europe Gynecological Cancer Drugs Market Overview 15.2. Western Europe Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Gynecological Cancer Drugs Market 16.1. UK Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Gynecological Cancer Drugs Market 17.1. Germany Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Gynecological Cancer Drugs Market 18.1. France Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Gynecological Cancer Drugs Market 19.1. Italy Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Gynecological Cancer Drugs Market 20.1. Spain Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Gynecological Cancer Drugs Market 21.1. Eastern Europe Gynecological Cancer Drugs Market Overview 21.2. Eastern Europe Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Gynecological Cancer Drugs Market 22.1. Russia Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Gynecological Cancer Drugs Market 23.1. North America Gynecological Cancer Drugs Market Overview 23.2. North America Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Gynecological Cancer Drugs Market 24.1. USA Gynecological Cancer Drugs Market Overview 24.2. USA Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Gynecological Cancer Drugs Market 25.1. Canada Gynecological Cancer Drugs Market Overview 25.2. Canada Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Gynecological Cancer Drugs Market 26.1. South America Gynecological Cancer Drugs Market Overview 26.2. South America Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Gynecological Cancer Drugs Market 27.1. Brazil Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Gynecological Cancer Drugs Market 28.1. Middle East Gynecological Cancer Drugs Market Overview 28.2. Middle East Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Gynecological Cancer Drugs Market 29.1. Africa Gynecological Cancer Drugs Market Overview 29.2. Africa Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Gynecological Cancer Drugs Market Competitive Landscape And Company Profiles 30.1. Gynecological Cancer Drugs Market Competitive Landscape 30.2. Gynecological Cancer Drugs Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Johnson & Johnson 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. F. Hoffmann-La Roche AG 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AbbVie Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Bayer AG 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Gynecological Cancer Drugs Market Other Major And Innovative Companies 31.1. Novartis AG 31.2. Bristol-Myers Squibb 31.3. Sanofi S.A. 31.4. AstraZeneca 31.5. Fresenius Kabi AG 31.6. GlaxoSmithKline 31.7. Takeda Pharmaceutical Company Limited 31.8. Eli Lilly and Company 31.9. Gilead Sciences Inc. 31.10. Amgen Inc. 31.11. Merck KGaA 31.12. Baxter International Inc. 31.13. Eisai Co. Ltd. 31.14. Sun Pharmaceutical Industries Ltd. 31.15. Teva Pharmaceutical Industries 32. Global Gynecological Cancer Drugs Market Competitive Benchmarking 33. Global Gynecological Cancer Drugs Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Gynecological Cancer Drugs Market 35. Gynecological Cancer Drugs Market Future Outlook and Potential Analysis 35.1 Gynecological Cancer Drugs Market In 2027 - Countries Offering Most New Opportunities 35.2 Gynecological Cancer Drugs Market In 2027 - Segments Offering Most New Opportunities 35.3 Gynecological Cancer Drugs Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
SummaryGynecological Cancer Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Gynecological Cancer Drugs Market Characteristics 3. Gynecological Cancer Drugs Market Trends And Strategies 4. Gynecological Cancer Drugs Market - Macro Economic Scenario 4.1. Impact Of High Inflation On Online Therapy Services Market 4.2. Ukraine-Russia War Impact On Online Therapy Services Market 4.3. COVID-19 Impact On Online Therapy Services Market 5.1. Global Gynecological Cancer Drugs Historic Market Size and Growth, 2017 - 2022, Value ($ Billion) 5.2. Global Gynecological Cancer Drugs Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion) 5.3. Global Gynecological Cancer Drugs Market Drivers and Restraints 5.3.1. Drivers Of The Market 5.3.2. Restraints Of The Market 6. Gynecological Cancer Drugs Market Segmentation 6.1. Global Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Alkylating Agent Plant Alkaloid Anthracyclines Antitumor Antibiotic Other Types 6.2. Global Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Chemotherapy Targeted Therapy Hormonal Therapy 6.3. Global Gynecological Cancer Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Cervical Cancer Uterine Cancer Ovarian and Fallopian Tube Cancer Vulvar Cancer Vaginal Cancer 6.4. Global Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion Hospitals Clinics Specialized Cancer Treatment Centers Other End Users 7. Gynecological Cancer Drugs Market Regional And Country Analysis 7.1. Global Gynecological Cancer Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 7.2. Global Gynecological Cancer Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8. Asia-Pacific Gynecological Cancer Drugs Market 8.1. Asia-Pacific Gynecological Cancer Drugs Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.3. Asia-Pacific Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 8.4. Asia-Pacific Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 9. China Gynecological Cancer Drugs Market 9.1. China Gynecological Cancer Drugs Market Overview 9.2. China Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.3. China Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 9.4. China Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion 10. India Gynecological Cancer Drugs Market 10.1. India Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.2. India Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 10.3. India Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11. Japan Gynecological Cancer Drugs Market 11.1. Japan Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.2. Japan Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 11.3. Japan Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12. Australia Gynecological Cancer Drugs Market 12.1. Australia Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.2. Australia Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 12.3. Australia Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13. Indonesia Gynecological Cancer Drugs Market 13.1. Indonesia Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.2. Indonesia Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 13.3. Indonesia Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14. South Korea Gynecological Cancer Drugs Market 14.1. South Korea Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.2. South Korea Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 14.3. South Korea Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15. Western Europe Gynecological Cancer Drugs Market 15.1. Western Europe Gynecological Cancer Drugs Market Overview 15.2. Western Europe Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.3. Western Europe Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 15.4. Western Europe Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16. UK Gynecological Cancer Drugs Market 16.1. UK Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.2. UK Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 16.3. UK Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17. Germany Gynecological Cancer Drugs Market 17.1. Germany Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.2. Germany Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 17.3. Germany Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18. France Gynecological Cancer Drugs Market 18.1. France Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.2. France Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 18.3. France Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19. Italy Gynecological Cancer Drugs Market 19.1. Italy Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.2. Italy Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 19.3. Italy Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20. Spain Gynecological Cancer Drugs Market 20.1. Spain Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.2. Spain Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 20.3. Spain Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21. Eastern Europe Gynecological Cancer Drugs Market 21.1. Eastern Europe Gynecological Cancer Drugs Market Overview 21.2. Eastern Europe Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.3. Eastern Europe Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 21.4. Eastern Europe Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22. Russia Gynecological Cancer Drugs Market 22.1. Russia Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.2. Russia Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 22.3. Russia Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23. North America Gynecological Cancer Drugs Market 23.1. North America Gynecological Cancer Drugs Market Overview 23.2. North America Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.3. North America Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 23.4. North America Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24. USA Gynecological Cancer Drugs Market 24.1. USA Gynecological Cancer Drugs Market Overview 24.2. USA Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.3. USA Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 24.4. USA Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25. Canada Gynecological Cancer Drugs Market 25.1. Canada Gynecological Cancer Drugs Market Overview 25.2. Canada Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.3. Canada Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 25.4. Canada Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26. South America Gynecological Cancer Drugs Market 26.1. South America Gynecological Cancer Drugs Market Overview 26.2. South America Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.3. South America Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 26.4. South America Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27. Brazil Gynecological Cancer Drugs Market 27.1. Brazil Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.2. Brazil Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 27.3. Brazil Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28. Middle East Gynecological Cancer Drugs Market 28.1. Middle East Gynecological Cancer Drugs Market Overview 28.2. Middle East Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.3. Middle East Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 28.4. Middle East Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29. Africa Gynecological Cancer Drugs Market 29.1. Africa Gynecological Cancer Drugs Market Overview 29.2. Africa Gynecological Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.3. Africa Gynecological Cancer Drugs Market, Segmentation By Therapeutic Modality, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 29.4. Africa Gynecological Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion 30. Gynecological Cancer Drugs Market Competitive Landscape And Company Profiles 30.1. Gynecological Cancer Drugs Market Competitive Landscape 30.2. Gynecological Cancer Drugs Market Company Profiles 30.2.1. Pfizer Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1.4. Financial Performance 30.2.2. Johnson & Johnson 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2.4. Financial Performance 30.2.3. F. Hoffmann-La Roche AG 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3.4. Financial Performance 30.2.4. AbbVie Inc. 30.2.4.1. Overview 30.2.4.2. Products and Services 30.2.4.3. Strategy 30.2.4.4. Financial Performance 30.2.5. Bayer AG 30.2.5.1. Overview 30.2.5.2. Products and Services 30.2.5.3. Strategy 30.2.5.4. Financial Performance 31. Gynecological Cancer Drugs Market Other Major And Innovative Companies 31.1. Novartis AG 31.2. Bristol-Myers Squibb 31.3. Sanofi S.A. 31.4. AstraZeneca 31.5. Fresenius Kabi AG 31.6. GlaxoSmithKline 31.7. Takeda Pharmaceutical Company Limited 31.8. Eli Lilly and Company 31.9. Gilead Sciences Inc. 31.10. Amgen Inc. 31.11. Merck KGaA 31.12. Baxter International Inc. 31.13. Eisai Co. Ltd. 31.14. Sun Pharmaceutical Industries Ltd. 31.15. Teva Pharmaceutical Industries 32. Global Gynecological Cancer Drugs Market Competitive Benchmarking 33. Global Gynecological Cancer Drugs Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Gynecological Cancer Drugs Market 35. Gynecological Cancer Drugs Market Future Outlook and Potential Analysis 35.1 Gynecological Cancer Drugs Market In 2027 - Countries Offering Most New Opportunities 35.2 Gynecological Cancer Drugs Market In 2027 - Segments Offering Most New Opportunities 35.3 Gynecological Cancer Drugs Market In 2027 - Growth Strategies 35.3.1 Market Trend Based Strategies 35.3.2 Competitor Strategies 36. Appendix 36.1. Abbreviations 36.2. Currencies 36.3. Historic And Forecast Inflation Rates 36.4. Research Inquiries 36.5. The Business Research Company 36.6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(cancer)の最新刊レポート
よくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/23 10:26 157.72 円 164.94 円 201.11 円 |